WHERE CUTTING EDGE INNOVATION AND COLLABORATION COME TOGETHER

Afrigen is a technology platform based biotech company.
Our PLatforms:
Artboard 1platform division

The objective of the technology transfer hub is to build mRNA vaccine production capacity in low- and middle-income countries through a center of excellence and training.

Vaccines are derived from killed, inactivated, or sub-unit bacteria or viruses, producing an immune response and providing immunity. Find out more about our developments and technology.

Encapsulation technologies extend shelf life, reduce evaporation and degradation, prevent interactions, improve sensory traits, control bioactive release, and enhance bioavailability.

High-quality products with complex pure and botanical mixtures, offering clinicians less-invasive, cost-effective therapeutic solutions for dosing and delivery of medicinal actives.

AFRIGEN IS MAKING HEADLINES

Please see below articles on where we have been featuring world wide. Be sure to visit our social pages for more updates.
Africa is home to some of the brightest minds who have not only excelled in their respective fields but have also made remarkable contributions to global progress. From groundbreaking scientific discoveries and innovations to leading transformative social and political movements, these individuals represent the pinnacle of intellectual brilliance. 
 
 ⏬ 
 
Read more about our Managing Director, Professor Petro Terblanche! 
 
https://businessday.ng/news/article/meet-9-influential-africans-report/ 
 
#Afrigenproud 
#Afrigen 
#biotechnology 
#mNRA
Showing the final bulk product manufactured at #Afrigen. 
 
🔹 🔬 🔹 🧪🔹 
 
#Afrigenbiologics 
#mRNA 
#technologytransfer 
#manufacturing 
 
🔹 
 
Medicines Patent Pool 
World Health Organization 
SINERGIUM Biotech
MRNA Technology Webinar with Dr. C Fenner ⏬ 
 
Click on the link to watch the video: https://www.youtube.com/watch?v=SBT9zGZi-Lc 
 
 🔹 Dr. Caryn Fenner, Executive Director of the mRNA Hub, Afrigen Biologics (Pty) Ltd will be discussing about mRNA technology platform development for Low- or Middle-Income Country (LMIC): The Afrigen case-study. Dr. Fenner has experience in bio manufacturing of recombinant proteins and therapeutics. 
 
Most recently Caryn has taken on the executive directorship of the Global mRNA technology development and transfer program, a WHO-led public/ private partnership consortium to advance mRNA vaccine development and manufacturing for Africa and other Low- or Middle-Income Countries (LMIC). 🔹 
 
#mRNAtechnology 
#afrigenbiologics 
#mRNAvaccine
🔹 Afrigen proudly welcomes Sinergium Biotech, Argentina.🇦🇷 
 
World Health Organization 
Medicines Patent Pool 
Afrigen Biologics (Pty) Ltd 
SINERGIUM Biotech 
 
#Afrigen 
#mRNA 
#mNRATechnologyTransferProgramme
Let's join Dr Caryn Fenner this Friday at the 7th Vaccinology Webinar. 
 
 🔹mRNA technology platform development for LMIC: The Afrigen case-study🔹 
 
Click here to register ⏬ 
https://events.teams.microsoft.com/event/b30edddf-3073-4828-8940-ac4737ec4e96@a5c0a820-c887-4727-ac66-403237d8c389 
 
#afrigen 
#afrigenbiologics 
#mNRAhub 
#casestudy
Happy Friday! Afrigen proudly welcomes Institute Torlak, Serbia. 
 
#Afrigen 
#mRNA
Afrigen is growing, and we have exciting job opportunities available. Visit https://www.afrigen.co.za/vacancies/ to find out more. 

IMPORTANT LINKS 🔗 IN PROFILE INFO ⬆️
 
#Afrigen
Afrigen Biologics proud to be associated with the International Society Society for Vaccines (ISV) and to support the annual conference in Seoul, South Korea on 21 to 23 October. 
 
#Afrigen 
#ISV 
#vaccines
Let's join Petro Terblanche - They will be discussing the latest trends, challenges and opportunities for life hashtag#science at BIO-Europe. Celebrating 30 years of facilitating partnerships, this year's event is not one to miss. 
 
Register to join: https://lnkd.in/dB8FK388 
 
Informa Connect 
Afrigen Biologics
Don’t miss @USPharmacopeia’s session tomorrow at #DCVMNAGM to hear Laura Martin and Petro Terblanche discuss ways to build regulatory capacity for vaccine approval for market use, highlighting experiences from African manufacturers. 
 
 ⏩ Learn more: https://ow.ly/7oj450TIQ1z 
 
#Afrigen 
#vaccines 
#manufacturers
Update on the #mRNA Technology Transfer Programme. 
 
--The mRNA Technology Transfer Programme, established by the World Health Organization (WHO) in partnership with the Medicines Patent Pool (MPP), was launched in July 2021 in response to the COVID-19 pandemic to address the global inequities in vaccine manufacturing. Its primary aim is to build mRNA vaccine manufacturing capacity in low- and middle-income countries (LMICs), thus bolstering health security through local and regional production.-- 
 
Click here to read more ▶️https://healthpolicy-watch.news/update-on-the-mrna-technology-transfer-programme/ 
 
#mRNA 
#mNRATechologyTransferProgramme 
#Afrigen
Preclinical evaluation in hamster model of the #mRNA COVID-19 vaccine candidate AfriVac 2121 (Wuhan) produced under the WHO/MPP mRNA Technology Transfer Programme. 
 
 ▶️ Read more: https://www.afrigen.co.za/2024/10/09/preclinical-evaluation-in-hamster-model-of-the-mrna-covid-19-vaccine-candidate-afrivac-2121-wuhan-produced-under-the-who-mpp-mrna-technology-transfer-programme/ 
 
#mRNA 
#mRNAtechnologytransferprogramme 
#Afrigen 
#WHO 
#MPP
Made in Africa mRNA Vaccines: A talk with Dr. Petro Terblanche of Afrigen Biologics & Vaccine.

⏭️Ben recently sat down with Dr. Petro Terblanche, the head of Afrigen, Africa’s first #mRNA vaccine researcher and manufacturer.  From the calamities of COVID-19 vaccine populism, the African public health community & its allies swore that never again would Africa be last in the line when it came to life saving pandemic #vaccines, and Petro sets out how this can - and is - being achieved, notwithstanding a wide array of challenges - and opposition.

Link in bio! 

#afrigenbiologics
#mRNAvaccineresearcher
#mRNAmanufacturer 

Afrigen
@who_africa 
@Coalition for Epidemic Preparedness Innovations - CEPI @MedicinesPatentPool 
Gavi, the Vaccine Alliance
Afrigen’s congratulates Bio-Sourcing on its fund-raising success and is excited to be a partner in bringing this innovative technology to Africa. 
 
Link in bio links✔️

#innovativetechnology 
#success 
#biosourcing
"We can change the world and make it a better place. It is in your hands to make a difference" 
 
~ Nelson Mandela 
 
HAPPY HERITAGE DAY 
 
#Afrigen #Afrigenbiologics #heritageday2024
Udder Health Market Analysis: Current Dynamics and Emerging Trends. 
 
Click on this link to read more ⏬ 
 
 🌐 https://www.lincolnnewsreporter.com/news/story/483110/udder-health-market-analysis-current-dynamics-and-emerging-trends.html 
 
#afrigenbiologics 
#mNRA
Visit our website, www.afrigen.co.za for all the latest updates. 
 
#afrigen 
#afrigenbiologics
CEPI partners with Afrigen to speed up #mRNAvaccine development and access. 🧬 
 
In a US$2.05 million CEPI-funded project, #researchers at Afrigen Biologics, a South African biotech company that is home to the #mRNA Technology Transfer Programme, will explore whether optimised synthetic DNA can help to reduce mRNA vaccine development timelines for emergency use in the event of a disease outbreak. The CEPI-Afrigen partnership supports the 100 Days Mission—a goal embraced by leaders of the G7 and G20 to reduce #vaccinedevelopment timelines to a little over three months in response to a pandemic threat. 
 
Visit the link for the full press release ⏬ 
https://www.afrigen.co.za/news-press-release-events/ 
 
@CEPI 
@Afrigenbiologics
🔬Afrigen Biologics was honoured to welcome a delegation from Ghana to their end-to-end #mRNA manufacturing and research facility. 
 
🔬The visit was facilitated by the African Vaccine Manufacturing Initiative (AVMI) and the South African Departments of Health and Science and Innovation represented during the visit by Dr Anban Pillay (Deputy Director General: Health) and Glaudina Loots (Director for Health Innovation). 
 
🔬The delegation was led by Ghana’s Minister of Health, Dr. Bernard Okoe-Boye and accompanied by Dr. Nana Ayew Afriye (MP), Dr. Delese Darko (CEO of Ghana FDA) and Prof. William Kwabena Ampofo (CEO of Ghana’s National Vaccine Institute). 
 
🔬Key collaborations like these and others enables Afrigen Biologics to fulfil our purpose of making a difference by supporting increased manufacturing capacity and capability while striving for equitable access to #vaccines across the continent and in our partner countries across the world. 
 
  #healthprofessionals #globalhealth
REPOST | @syngoitechnologies 
 
 🌐🔬 Join our next webinar “Accelerating mRNA Production: Leveraging synthetic DNA for enhanced IVT efficiency and rapid delivery"! The event on the 28th of August is just around the corner. 
 
📅 Date: 28 August 
🕒 Time: 12 PM ET (6 PM CEST). 
 
🌟 Hosted by Hanson Wade and Syngoi, featuring leading speakers from Syngoi Technologies, Quantoom Biosciences, Recipharm, Afrigen Biologics (Pty) Ltd 
 
👩‍💼👨‍💼 Discover the latest innovations in mRNA production and how synthetic DNA technology is revolutionizing efficiency in Vitro Transcription (IVT). 
 
Register now to secure your spot! ▶️ https://lnkd.in/dndj_KyW 
 
#Webinar #mRNAProduction #SyntheticDNA #Biotechnology #Innovation #afrigen
“A WOMAN IS THE FULL CIRCLE. WITHIN HER IS THE POWER TO CREATE, NURTURE AND TRANSFORM’’ – Diane Mariechild

We salute the women of the world and proudly acknowledge the female scientists, engineers, pharmacist, accountants, HR specialist, and support staff in Afrigen for their substantial contribution to innovation for health. And we appreciate the support of our male colleagues.

🔸🔹

Afrigen 
#womensday2024